A Broad Spectrum Anti-Parasitic, Anti-Inflammatory Supplement.

A highly effective anti-parasitic supplement known for its versatile activity, proven safety profile, and successful use since 1987.

SHOP NOW

Ivermectin has been studied for its ability to inhibit the replication of various pathogens in laboratory settings, including:

  • Respiratory Viruses: Research has explored its potential to disrupt protein transport mechanisms involved in viral replication.
  • Flaviviruses: Investigations have demonstrated its activity against certain viruses in this category, such as those responsible for mosquito-borne illnesses.
  • Other Viral Agents: Preliminary studies suggest ivermectin may have broader applications.

Ivermectin has demonstrated the ability to reduce inflammation by:

  • Suppressing the release of pro-inflammatory cytokines, such as TNF-α and IL-6.
  • Modulating immune system responses, which could benefit autoimmune or inflammatory conditions.

Ivermectin has shown promise in oncology research, with evidence suggesting it:

  • Inhibits tumor growth in cancers such as breast, colorectal, lung, and stomach cancers.
  • Enhances chemotherapy sensitivity by overcoming drug resistance.
  • Targets cancer stem cells and modifies the tumor microenvironment.

Ivermectin appears to interact with immune pathways, offering potential benefits such as:

  • Reducing populations of immunosuppressive cells (e.g., Tregs and myeloid-derived suppressor cells).
  • Enhancing the body’s ability to mount an immune response against infections and tumors.

Although ivermectin doesn’t readily cross the blood-brain barrier in healthy individuals, it has been studied for its effects on:

  • Neurodegenerative Diseases: Potential to modulate pathways involved in diseases like Alzheimer’s.
  • Epilepsy and Seizures: Some research indicates it may help control seizures in specific contexts.

There is emerging evidence that ivermectin may have antibacterial properties, particularly against gram-positive bacteria like Staphylococcus aureus.

In addition to treating scabies, ivermectin has been explored for:

  • Rosacea: FDA-approved for topical use to reduce skin inflammation and lesions.
  • Head Lice: An effective treatment for infestations.
  • Acne: Potential for reducing inflammation and bacterial presence in severe acne.

Preliminary studies have suggested that ivermectin’s modulation of cellular pathways, such as autophagy, could contribute to anti-aging effects and cellular repair mechanisms.

Ivermectin has shown activity against some fungi in lab studies, though its clinical relevance is not well-established.

  • Metabolic Diseases: Modulation of insulin signaling pathways has led to speculation about its potential in managing metabolic disorders.
  • Cardiovascular Health: Anti-inflammatory effects may reduce the risk of cardiovascular complications linked to chronic inflammation.